Inflexion’s investment in Cawood Scientific

Inflexion has completed the buyout of Cawood Scientific, the UK’s largest independent provider of analytical laboratory testing services for land-based industries.

Founded over 25 years ago, Cawood delivers highly accredited analytical services to organisations within the agriculture and renewable energy sectors. The business serves over 3,500 customers across three divisions; NRM Laboratories, Sciantec Analytical and Sci-Tech Laboratories. Its c.170 employees operate across four laboratories in Berkshire, Yorkshire, Shropshire and Norfolk.

Cawood’s growth is underpinned by market tailwinds as food quality assurance and agricultural efficiencies increasingly demand a larger share of the political agenda. The company is at forefront of developments in the agricultural sector as testing and data analytics play a key role in quality control and sustainable food production.

Strata Partners has acted as exclusive corporate finance adviser to Inflexion on its investment in Cawood Scientific.

Inflexion is one of the UK’s leading independent mid-market private equity houses and comes in to work in partnership with Cawood Scientific to support its next phase of growth.

Weightmans has advised the management team of Cawood Scientific on the deal with a corporate team was led by Gary Jones and included Ben Davies and Haydn Rogan.

Addleshaw Goddard has advised leading private equity house Inflexion on the deal with a team led by Paul Medlicott (picture), and included George Danczak and Joanne Cooper.

Involved fees earner: Gary Jones – Weightmans LLP; Ben Davies – Weightmans LLP; Haydn Rogan – Weightmans LLP; Paul Medlicott – Addleshaw Goddard; George Danczak – Addleshaw Goddard; Joanne Cooper – Addleshaw Goddard;

Law Firms: Weightmans LLP; Addleshaw Goddard;

Clients: Inflexion Private Equity; Cawood Scientific;

Print Friendly, PDF & Email